The proposed bill, known as the "Doug Cameron Act," aims to establish a moratorium on the use of human gene therapy products for infectious diseases in Idaho. This legislation is motivated by the intent to protect the health and safety of Idaho citizens, particularly following the severe injury of Doug Cameron, who was left disabled after receiving a genetic immunization. The bill defines "human gene therapy product" and includes various forms of genetic material and modified organisms. It explicitly prohibits the administration of these products for infectious disease indications, regardless of the terminology used, such as immunizations or vaccines.

The moratorium will remain in effect until July 1, 2035, and will be subject to legislative review based on available safety data. However, the provisions of this act do not apply to human gene therapy products used for the treatment of cancer or genetic disorders. The bill declares an emergency, making it effective starting July 1, 2025.